BECLOMETHASONE DIPROPIONATE
Drug
Chiesi USA, Inc.
Total Payments
$733,851
Transactions
218
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $733,851 | 218 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $733,851 | 218 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CCD-05993AA3-01 | Chiesi USA, Inc. | $733,851 | 0 |
Top Doctors Receiving Payments for BECLOMETHASONE DIPROPIONATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Colorado Springs, CO | $733,851 | 218 |
Ad
Manufacturing Companies
- Chiesi USA, Inc. $733,851
Product Information
- Type Drug
- Total Payments $733,851
- Total Doctors 0
- Transactions 218
About BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE is a drug associated with $733,851 in payments to 0 healthcare providers, recorded across 218 transactions in the CMS Open Payments database. The primary manufacturer is Chiesi USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $733,851 was paid across 218 transactions to 0 doctors.
The most common payment nature for BECLOMETHASONE DIPROPIONATE is "Unspecified" ($733,851, 100.0% of total).
BECLOMETHASONE DIPROPIONATE is associated with 1 research study, including "CCD-05993AA3-01" ($733,851).